Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
251 USD | +0.94% | +3.30% | +31.15% |
07-03 | Jerome Powell did it again | |
07-03 | JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.15% | 31.46B | |
+18.97% | 44.44B | |
+41.98% | 40.03B | |
-10.06% | 37.68B | |
-7.79% | 27.29B | |
+13.32% | 26.29B | |
+43.05% | 13.8B | |
+31.28% | 12.46B | |
-7.41% | 11.26B | |
-15.54% | 10.38B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160